Work

Management of psoriasis vulgaris and multiple sclerosis with fumaric acid

Year: 2014

Type: article

Abstract: To the Editor: Psoriasis vulgaris has not only been associated with several comorbidities like metabolic syndrome and cardiovascular disease, but also with neurologic disorders like multiple sclerosis (MS).1 New-onset psoriatic lesions and exacerbations have been described after treatment with biologics for MS, mainly interferon-beta (INF-β) as well as with other biologics such as natalizumab.2 INF-β is the first-line treatment for clinically isolated syndrome with the high risk for MS development or for relapsing-remitting multiple sclerosis (RR-MS).

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2013.10.031

Authors: Spyridon Gkalpakiotis, Petr Arenberger, Petra Gkalpakioti, Eva Meluzinova, Devika Chandran, Monika Arenbergerova

Institutions: Charles University, University Hospital Kralovske Vinohrady, University Hospital in Motol

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,200